Safety and efficacy of 12 mg/d lenvatinib (LEN) in patients with unresectable hepatocellular carcinoma (uHCC) and bodyweight (bw) >80 kg in REFLECT Meeting Abstract
| Authors: | Vogel, A.; Kudo, M.; Cheng, A. L.; Sung, M. W.; Finn, R. S.; Lin, A. Y.; Abou-Alfa, G. K.; Alsina, A.; Breder, V.; Tebbutt, N.; Osterlund, P.; Yen, C. J.; Ren, M.; Misir, S.; Dutcus, C. E.; Palmer, D.; Merle, P.; Pinter, M.; Evans, T. J. |
| Abstract Title: | Safety and efficacy of 12 mg/d lenvatinib (LEN) in patients with unresectable hepatocellular carcinoma (uHCC) and bodyweight (bw) >80 kg in REFLECT |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 42 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 11-14 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2019-10-01 |
| Start Page: | 242 |
| End Page: | 243 |
| Language: | English |
| ACCESSION: | WOS:000568159600585 |
| PROVIDER: | wos |
| DOI: | 10.1159/000502425 |
| Notes: | "Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Meeting Abstract: V893 -- Source: Wos |
